Conmed (CNMD) announced the departure of Todd Garner from his role as CFO, effective March 15. To ensure a smooth and orderly transition, Garner will remain with the company in an advisory capacity through November 2. Conmed has initiated a comprehensive search process, supported by a leading executive search firm, to identify its next CFO.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNMD:
- Conmed announces 1-for-40 reverse share split
- Conmed price target lowered to $52 from $65 at BofA
- Conmed’s Strategic Exit from Gastroenterology: Hold Rating Amid Portfolio Optimization and Financial Adjustments
- Roth Capital healthcare analyst holds an analyst/industry conference call
- Midday Fly By: Netflix to buy Warner Bros., HP Enterprise posts mixed Q4